InsidersTradesSigma
Track the CYNATA THERAPEUTICS LIMITED stock price and the full insider trade history of the company, a listed issuer based in Australia. Shares trade on the AU market, under the supervision of ASX. Market capitalisation: €2.7m. The latest transaction was reported on 2 July 2026 (Cease Substantial Holding). Among the most active insiders: 2. Changes in relevant interests. Every trade is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Cynata Therapeutics Limited 是一家澳大利亚生物制药公司，专注于开发细胞疗法。该公司利用其干细胞生产平台来治疗各种疾病。